These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31979111)

  • 1. In-silico Analysis of
    Accetturo M; Bartolomeo N; Stella A
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31979111
    [No Abstract]   [Full Text] [Related]  

  • 2. Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.
    Isakov O; Wallis D; Evans DG; Ben-Shachar S
    EBioMedicine; 2018 Oct; 36():508-516. PubMed ID: 30274822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AI-derived comparative assessment of the performance of pathogenicity prediction tools on missense variants of breast cancer genes.
    Ahmad RM; Ali BR; Al-Jasmi F; Al Dhaheri N; Al Turki S; Kizhakkedath P; Mohamad MS
    Hum Genomics; 2024 Sep; 18(1):99. PubMed ID: 39256852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curated multiple sequence alignment for the Adenomatous Polyposis Coli (APC) gene and accuracy of in silico pathogenicity predictions.
    Karabachev AD; Martini DJ; Hermel DJ; Solcz D; Richardson ME; Pesaran T; Sarkar IN; Greenblatt MS
    PLoS One; 2020; 15(8):e0233673. PubMed ID: 32750050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurofibromin (NF1) genetic variant structure-function analyses using a full-length mouse cDNA.
    Wallis D; Li K; Lui H; Hu K; Chen MJ; Li J; Kang J; Das S; Korf BR; Kesterson RA
    Hum Mutat; 2018 Jun; 39(6):816-821. PubMed ID: 29522274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA.
    Tsipi M; Poulou M; Fylaktou I; Kosma K; Tsoutsou E; Pons MR; Kokkinou E; Kitsiou-Tzeli S; Fryssira H; Tzetis M
    J Neurol Sci; 2018 Dec; 395():95-105. PubMed ID: 30308447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and Recurring Disease-Causing NF1 Variants in Two Chinese Families with Neurofibromatosis Type 1.
    Xiao H; Yuan L; Xu H; Yang Z; Huang F; Song Z; Yang Y; Zeng C; Deng H
    J Mol Neurosci; 2018 Aug; 65(4):557-563. PubMed ID: 30046999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Empirically downgrading 10 constitutional missense variants of the NF1 gene based on co-existing truncating variants.
    Kluwe L; Mautner VF
    Am J Med Genet A; 2021 Feb; 185(2):602-603. PubMed ID: 33231931
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical spectrum of individuals with pathogenic NF1 missense variants affecting p.Met1149, p.Arg1276, and p.Lys1423: genotype-phenotype study in neurofibromatosis type 1.
    Koczkowska M; Callens T; Chen Y; Gomes A; Hicks AD; Sharp A; Johns E; Uhas KA; Armstrong L; Bosanko KA; Babovic-Vuksanovic D; Baker L; Basel DG; Bengala M; Bennett JT; Chambers C; Clarkson LK; Clementi M; Cortés FM; Cunningham M; D'Agostino MD; Delatycki MB; Digilio MC; Dosa L; Esposito S; Fox S; Freckmann ML; Fauth C; Giugliano T; Giustini S; Goetsch A; Goldberg Y; Greenwood RS; Griffis C; Gripp KW; Gupta P; Haan E; Hachen RK; Haygarth TL; Hernández-Chico C; Hodge K; Hopkin RJ; Hudgins L; Janssens S; Keller K; Kelly-Mancuso G; Kochhar A; Korf BR; Lewis AM; Liebelt J; Lichty A; Listernick RH; Lyons MJ; Maystadt I; Martinez Ojeda M; McDougall C; McGregor LK; Melis D; Mendelsohn N; Nowaczyk MJM; Ortenberg J; Panzer K; Pappas JG; Pierpont ME; Piluso G; Pinna V; Pivnick EK; Pond DA; Powell CM; Rogers C; Ruhrman Shahar N; Rutledge SL; Saletti V; Sandaradura SA; Santoro C; Schatz UA; Schreiber A; Scott DA; Sellars EA; Sheffer R; Siqveland E; Slopis JM; Smith R; Spalice A; Stockton DW; Streff H; Theos A; Tomlinson GE; Tran G; Trapane PL; Trevisson E; Ullrich NJ; Van den Ende J; Schrier Vergano SA; Wallace SE; Wangler MF; Weaver DD; Yohay KH; Zackai E; Zonana J; Zurcher V; Claes KBM; Eoli M; Martin Y; Wimmer K; De Luca A; Legius E; Messiaen LM
    Hum Mutat; 2020 Jan; 41(1):299-315. PubMed ID: 31595648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance evaluation of pathogenicity-computation methods for missense variants.
    Li J; Zhao T; Zhang Y; Zhang K; Shi L; Chen Y; Wang X; Sun Z
    Nucleic Acids Res; 2018 Sep; 46(15):7793-7804. PubMed ID: 30060008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison and optimization of in silico algorithms for predicting the pathogenicity of sodium channel variants in epilepsy.
    Holland KD; Bouley TM; Horn PS
    Epilepsia; 2017 Jul; 58(7):1190-1198. PubMed ID: 28518218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the potential pathogenicity of missense mutations identified in the GTPase-activating protein (GAP)-related domain of the neurofibromatosis type-1 (NF1) gene.
    Thomas L; Richards M; Mort M; Dunlop E; Cooper DN; Upadhyaya M
    Hum Mutat; 2012 Dec; 33(12):1687-96. PubMed ID: 22807134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome sequencing revealed a likely pathogenic variant in NF1 causing neurofibromatosis type I and Arrhythmogenic Cardiomyopathy.
    Pourirahim M; Houshmand G; Abdolkarimi L; Maleki M; Kalayinia S
    BMC Cardiovasc Disord; 2024 Apr; 24(1):220. PubMed ID: 38654147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of MEFV gene variants classification to aid treatment decision making in familial Mediterranean fever.
    Accetturo M; D'Uggento AM; Portincasa P; Stella A
    Rheumatology (Oxford); 2020 Apr; 59(4):754-761. PubMed ID: 31411330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reassessment of the NF1 variants of unknown significance found during the 20-year activity of a genetics diagnostic laboratory.
    Martorana D; Barili V; Uliana V; Ambrosini E; Riva M; De Sensi E; Luppi E; Messina C; Caleffi E; Pisani F; Percesepe A
    Eur J Med Genet; 2023 Nov; 66(11):104847. PubMed ID: 37751797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.
    Chen J; Li Z; Wu Y; Li X; Chen Z; Chen P; Ding Y; Wu C; Hu L
    J Mol Neurosci; 2024 Oct; 74(4):94. PubMed ID: 39373898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-Type Calcium Channel: Predicting Pathogenic/Likely Pathogenic Status for Variants of Uncertain Clinical Significance.
    Tarnovskaya SI; Kostareva AA; Zhorov BS
    Membranes (Basel); 2021 Aug; 11(8):. PubMed ID: 34436362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice with missense and nonsense NF1 mutations display divergent phenotypes compared with human neurofibromatosis type I.
    Li K; Turner AN; Chen M; Brosius SN; Schoeb TR; Messiaen LM; Bedwell DM; Zinn KR; Anastasaki C; Gutmann DH; Korf BR; Kesterson RA
    Dis Model Mech; 2016 Jul; 9(7):759-67. PubMed ID: 27482814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of a Protein Language Model for Variant Annotation in Cardiac Disease.
    Hochstadt A; Barbhaiya C; Aizer A; Bernstein S; Cerrone M; Garber L; Holmes D; Knotts RJ; Kushnir A; Martin J; Park D; Spinelli M; Yang F; Chinitz LA; Jankelson L
    J Am Heart Assoc; 2024 Oct; 13(20):e036921. PubMed ID: 39392163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants.
    Ioannidis NM; Rothstein JH; Pejaver V; Middha S; McDonnell SK; Baheti S; Musolf A; Li Q; Holzinger E; Karyadi D; Cannon-Albright LA; Teerlink CC; Stanford JL; Isaacs WB; Xu J; Cooney KA; Lange EM; Schleutker J; Carpten JD; Powell IJ; Cussenot O; Cancel-Tassin G; Giles GG; MacInnis RJ; Maier C; Hsieh CL; Wiklund F; Catalona WJ; Foulkes WD; Mandal D; Eeles RA; Kote-Jarai Z; Bustamante CD; Schaid DJ; Hastie T; Ostrander EA; Bailey-Wilson JE; Radivojac P; Thibodeau SN; Whittemore AS; Sieh W
    Am J Hum Genet; 2016 Oct; 99(4):877-885. PubMed ID: 27666373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.